Cleared Traditional

K944923 - CKMB/MYOGLOBIN MASS MEASUREMENY CONTROL LEVEL 1, 2, 3,

K944923 is an FDA 510(k) clearance for CKMB/MYOGLOBIN MASS MEASUREMENY CONTROL..., manufactured by Clinical Controls, Inc.. The device is a Class 1 Chemistry device with product code JJT cleared through the Traditional 510(k) pathway after a 29-day FDA review.

K944923 · Clinical Controls, Inc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 1994
Decision
29d
Days
Class 1
Risk

K944923 is an FDA 510(k) clearance for the CKMB/MYOGLOBIN MASS MEASUREMENY CONTROL LEVEL 1, 2, 3,. Classified as Enzyme Controls (assayed And Unassayed) (product code JJT), Class I - General Controls.

Submitted by Clinical Controls, Inc. (Grover Beach, US). The FDA issued a Cleared decision on November 4, 1994 after a review of 29 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1660 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Clinical Controls, Inc. devices

FDA 510(k) Submission Details - K944923

510(k) Number K944923 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 06, 1994
Decision Date November 04, 1994
Days to Decision 29 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
59d faster than avg
Panel avg: 88d · This submission: 29d
Pathway characteristics
Predicate-based equivalence.

JJT Device Classification - Class 1, General Controls

Product Code JJT Enzyme Controls (assayed And Unassayed)
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1660
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - JJT Enzyme Controls (assayed And Unassayed)

All 79
Devices cleared under the same product code (JJT) and FDA review panel - the closest regulatory comparables to K944923.
CARDIO REP LD CONTROL - CAT NO. 3325
K950801 · Helena Laboratories · Mar 1995
CARDIOSPEX(TM) CKMB/LD-1 IMMUNOINHIBITION CONTROL
K946145 · Clinical Controls, Inc. · Jan 1995
CARDIOSPEX(TM) LIQUID CKMB/LD-1 IMMUNOINHIBITION
K946146 · Clinical Controls, Inc. · Jan 1995
HICHEM ENZYME VERIFIER KIT
K943684 · Hi Chem, Inc. · Oct 1994
CARDIO REP RECOMBINANT CK ABNORMAL CONTROL
K932442 · Helena Laboratories · Oct 1993
ROCHE CARDIOTROL-CK
K930889 · Roche Diagnostic Systems, Inc. · Jul 1993